Rare diseases
Investigational molecules
Locations
Phase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease
SpainLong‑term safety study of alpelisib alone or with fulvestrant in adults with breast cancer who benefited from previous alpelisib treatment
SpainStudy of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)
SpainFirst‑Line Study of Zoldonrasib (RMC‑9805) Drug Combination vs Gemcitabine/Nab‑Paclitaxel in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Cancer
SpainA Phase 2 Study of LAD603 in Adults with Systemic Lupus Erythematosus and Active Skin Rash
SpainSafety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1
SpainStudy of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy
SpainSensitivity and Specificity of Blomia tropicalis Extract, Histamine Dihydrochloride and Sodium Chloride in Skin Prick Test for Patients with Blomia tropicalis Allergy
SpainPhase 2 Randomized Trial of Oral NS-863 in Patients with Pulmonary Arterial Hypertension
SpainA Phase III Study of AZD0120 versus melphalan hydrochloride with lenalidomide maintenance in transplant‑eligible adults with newly diagnosed multiple myeloma
SpainStudy of ATX-898 alone and in drug combination for patients with advanced solid tumors
SpainStudy of ARGX-121 to Reduce Proteinuria in Adults with Primary IgA Nephropathy (IgAN)
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
